{
    "hands_on_practices": [
        {
            "introduction": "This practice focuses on a core skill in evidence-based medicine: calculating relative risk. Understanding how to quantify the proportional increase in risk, such as for venous thromboembolism (VTE) with combined hormonal contraceptives, is essential for translating population data into meaningful counseling for an individual patient. This exercise will guide you through this fundamental calculation, forming the basis for more complex risk-benefit discussions. ",
            "id": "4819674",
            "problem": "A patient in internal medicine clinic is considering a combined hormonal contraceptive (CHC) containing ethinyl estradiol and a progestin. As part of contraception counseling, you wish to quantify the proportional increase in venous thromboembolism (VTE) risk attributable to CHC use relative to nonuse. Assume the following, consistent with epidemiologic conventions:\n\n- Incidence rate is defined as events per person-time (here, woman-years), and population rates are stable over the counseling horizon.\n- The observed population incidence rate for VTE among healthy reproductive-age nonusers is 2 per 10,000 woman-years.\n- The observed population incidence rate for VTE among CHC users is 6 per 10,000 woman-years.\n\nUsing standard epidemiologic definitions of incidence rate and proportional risk change between an exposed group and an unexposed group, compute the relative risk increase for CHC users compared to nonusers. Express your final answer as a unitless decimal or fraction (do not use a percentage sign). No rounding is required.",
            "solution": "The problem is first validated against the required criteria.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n- The quantity of interest is the \"proportional increase in venous thromboembolism (VTE) risk attributable to CHC use relative to nonuse,\" also termed the \"relative risk increase.\"\n- The incidence rate for VTE among nonusers (unexposed group) is 2 per 10,000 woman-years.\n- The incidence rate for VTE among CHC users (exposed group) is 6 per 10,000 woman-years.\n- The final answer is to be expressed as a unitless decimal or fraction.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded:** The problem uses standard, well-defined concepts from epidemiology, namely incidence rates and relative risk. The provided incidence rates for VTE in reproductive-age women, both with and without combined hormonal contraceptive (CHC) use, are consistent with data from large-scale observational studies. The problem is firmly grounded in medical science and epidemiology.\n- **Well-Posed:** The problem provides all necessary data to calculate the requested quantity. The terminology (\"incidence rate,\" \"relative risk increase\") is standard and allows for the computation of a unique, meaningful solution.\n- **Objective:** The problem is stated in precise, objective language, free of subjective claims or bias.\n\n**Step 3: Verdict and Action**\nThe problem is deemed **valid** as it is scientifically grounded, well-posed, objective, and contains sufficient information for a unique solution. A full solution is therefore warranted.\n\n### Solution\n\nThe problem requires the calculation of the relative risk increase for venous thromboembolism (VTE) among users of combined hormonal contraceptives (CHCs) compared to nonusers. We will use standard epidemiologic definitions.\n\nLet $I_{exposed}$ be the incidence rate of VTE in the exposed group (CHC users).\nLet $I_{unexposed}$ be the incidence rate of VTE in the unexposed group (nonusers).\n\nFrom the problem statement, we are given:\n$$ I_{unexposed} = \\frac{2}{10000} \\text{ woman-years}^{-1} $$\n$$ I_{exposed} = \\frac{6}{10000} \\text{ woman-years}^{-1} $$\n\nThe \"relative risk increase\" ($RRI$) is the measure that quantifies the proportional increase in risk in the exposed group relative to the baseline risk in the unexposed group. It is calculated as the risk difference (or attributable risk) divided by the baseline risk in the unexposed group.\n\nThe risk difference, which is the absolute excess risk attributable to the exposure, is given by:\n$$ \\text{Risk Difference} = I_{exposed} - I_{unexposed} $$\n\nThe relative risk increase is this excess risk expressed as a fraction of the unexposed risk:\n$$ RRI = \\frac{I_{exposed} - I_{unexposed}}{I_{unexposed}} $$\n\nSubstituting the given values into this formula:\n$$ RRI = \\frac{\\frac{6}{10000} - \\frac{2}{10000}}{\\frac{2}{10000}} $$\n\nThe common factor of $\\frac{1}{10000} \\text{ woman-years}^{-1}$ in the numerator and denominator cancels out, simplifying the calculation to a ratio of the rate numbers:\n$$ RRI = \\frac{6 - 2}{2} = \\frac{4}{2} = 2 $$\n\nAlternatively, one can first compute the Relative Risk ($RR$), which is the ratio of the incidence rate in the exposed group to that in the unexposed group:\n$$ RR = \\frac{I_{exposed}}{I_{unexposed}} = \\frac{6/10000}{2/10000} = \\frac{6}{2} = 3 $$\nThis means the risk of VTE is $3$ times higher in CHC users compared to nonusers.\n\nThe relative risk increase can then be calculated from the relative risk:\n$$ RRI = RR - 1 $$\nThis is because:\n$$ RRI = \\frac{I_{exposed} - I_{unexposed}}{I_{unexposed}} = \\frac{I_{exposed}}{I_{unexposed}} - \\frac{I_{unexposed}}{I_{unexposed}} = RR - 1 $$\nUsing the calculated value of $RR$:\n$$ RRI = 3 - 1 = 2 $$\n\nBoth methods yield the same result. The relative risk increase is $2$. This is a unitless quantity, representing that the additional risk from CHC use is $2$ times the baseline risk (or a $200\\%$ increase over the baseline risk). The problem requests the answer as a unitless decimal or fraction, so $2$ is the final answer.",
            "answer": "$$\\boxed{2}$$"
        },
        {
            "introduction": "Moving beyond relative comparisons, this exercise introduces two powerful metrics for clinical decision-making: Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT). By calculating the ARR, you can communicate the direct benefit of switching to a more effective contraceptive method in terms of pregnancy prevention. The NNT further contextualizes this by estimating how many patients need to make the switch to prevent one unintended pregnancy, offering a highly intuitive tool for shared decision-making. ",
            "id": "4819703",
            "problem": "A patient in an internal medicine clinic seeks counseling on contraception. She currently uses a method with a typical-use failure rate of 0.07 per person-year and is considering switching to a method with a typical-use failure rate of 0.005 per person-year. For this counseling scenario, interpret the typical-use failure rate as the probability of pregnancy over a one-year horizon under real-world adherence. Using the accepted definitions of Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT), compute the reduction in the one-year probability of pregnancy when switching methods and the corresponding NNT for preventing one pregnancy over one year through this switch. Express the ARR as a decimal and the NNT as an exact fraction in lowest terms. Do not use percentage signs, and do not include any units in your final values.",
            "solution": "The problem is first subjected to validation.\n\n### Step 1: Extract Givens\n-   Typical-use failure rate of the current contraceptive method: $0.07$ per person-year.\n-   Typical-use failure rate of the new contraceptive method: $0.005$ per person-year.\n-   Definition: The typical-use failure rate is to be interpreted as the probability of pregnancy over a one-year horizon.\n-   Objective: Compute the Absolute Risk Reduction (ARR) and the Number Needed to Treat (NNT).\n-   Output format for ARR: decimal.\n-   Output format for NNT: exact fraction in lowest terms.\n\n### Step 2: Validate Using Extracted Givens\n1.  **Scientific Grounding**: The problem is scientifically grounded. The scenario describes a standard clinical counseling situation in internal medicine. The concepts of \"typical-use failure rate,\" \"Absolute Risk Reduction (ARR),\" and \"Number Needed to Treat (NNT)\" are fundamental, well-defined metrics in epidemiology and evidence-based medicine. The numerical values provided for the failure rates ($0.07$ and $0.005$) are realistic for existing contraceptive methods (e.g., corresponding to the typical-use one-year failure probabilities of birth control pills and an intrauterine device (IUD), respectively).\n2.  **Well-Posedness**: The problem is well-posed. It provides all necessary data and definitions to arrive at a unique solution. The definitions of ARR and NNT are standard and unambiguous.\n3.  **Objectivity**: The language is objective and precise, presenting a quantitative task based on given data without subjective or opinion-based elements.\n4.  **Completeness and Consistency**: The problem is self-contained and free of contradictions. The interpretation of failure rate as a one-year probability is explicitly stated, removing ambiguity.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid** as it is scientifically grounded, well-posed, and objective. A solution will now be derived.\n\n### Solution Derivation\n\nThe problem requires the calculation of two standard epidemiological measures: Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT).\n\nLet $P_{current}$ be the probability of the adverse outcome (pregnancy) for a patient using the current method over a one-year horizon. This is the event rate in the control or baseline group.\nFrom the problem statement,\n$$P_{current} = 0.07$$\n\nLet $P_{new}$ be the probability of the adverse outcome (pregnancy) for a patient who switches to the new method over a one-year horizon. This is the event rate in the treatment or intervention group.\nFrom the problem statement,\n$$P_{new} = 0.005$$\n\nThe Absolute Risk Reduction (ARR) is defined as the absolute difference in the event rates between the control group and the treatment group. It quantifies the reduction in risk attributable to the intervention.\n$$ARR = P_{control} - P_{treatment}$$\nIn this context, the \"control\" is the current method and the \"treatment\" is the new method.\n$$ARR = P_{current} - P_{new}$$\nSubstituting the given values:\n$$ARR = 0.07 - 0.005 = 0.065$$\nThe problem specifies that the ARR should be expressed as a decimal, which it is.\n\nThe Number Needed to Treat (NNT) is the reciprocal of the Absolute Risk Reduction. It represents the average number of patients who must receive the treatment (switch to the new method) for a specific duration (one year) to prevent one additional adverse outcome (one pregnancy).\n$$NNT = \\frac{1}{ARR}$$\nUsing the calculated value of ARR:\n$$NNT = \\frac{1}{0.065}$$\nThe problem requires the NNT to be expressed as an exact fraction in lowest terms. To do this, we convert the decimal to a fraction:\n$$0.065 = \\frac{65}{1000}$$\nTherefore,\n$$NNT = \\frac{1}{\\frac{65}{1000}} = \\frac{1000}{65}$$\nTo reduce this fraction to its lowest terms, we find the greatest common divisor of the numerator and the denominator. Both $1000$ and $65$ are divisible by $5$.\n$$\\frac{1000 \\div 5}{65 \\div 5} = \\frac{200}{13}$$\nThe number $13$ is a prime number. Since $200$ is not a multiple of $13$ ($13 \\times 15 = 195$), the fraction $\\frac{200}{13}$ is in its lowest terms.\n\nThe two computed values are the ARR, which is $0.065$, and the NNT, which is $\\frac{200}{13}$. The final answer should be presented as a row matrix.",
            "answer": "$$\\boxed{\\begin{pmatrix} 0.065 & \\frac{200}{13} \\end{pmatrix}}$$"
        },
        {
            "introduction": "Clinical counseling often requires navigating scenarios that don't fit neatly into pre-calculated statistics. This advanced practice challenges you to build a patient-specific risk model from first principles. By integrating variables such as ovulation timing, the fertile window, and the efficacy of backup methods, you will learn to construct a quantitative argument to estimate the probability of pregnancy in a complex \"quick start\" scenario, honing your skills in personalized risk assessment. ",
            "id": "4819590",
            "problem": "A patient with regular $28$-day menstrual cycles presents for contraception counseling. She quick-starts Combined Oral Contraceptives (COCs) on cycle day $16$ and is advised to use backup contraception for $7$ consecutive days. She wishes to understand the probability of unintended pregnancy in this cycle, given the following scientifically grounded assumptions about exposure and fertility:\n\n- Actual ovulation day $O$ varies uniformly across $\\{14, 15, 16\\}$ (reflecting typical mid-cycle variability), so $\\mathbb{P}(O = 14) = \\mathbb{P}(O = 15) = \\mathbb{P}(O = 16) = \\frac{1}{3}$.\n- The fertile window is defined as the set of days $\\{O-2, O-1, O, O+1\\}$, consistent with sperm survival and oocyte viability.\n- Per-act probability of conception with unprotected vaginal intercourse depends on the day relative to ovulation, with the following values: $p_{-2} = 0.15$, $p_{-1} = 0.25$, $p_{0} = 0.30$, $p_{+1} = 0.08$, and $0$ on days outside the fertile window.\n- A single unprotected intercourse occurred on cycle day $14$ prior to COC initiation.\n- During the $7$-day backup interval after quick-starting COCs, the patient had intercourse on cycle days $16$, $18$, and $20$, each time using a male condom correctly. Consistent condom use reduces the per-act conception probability multiplicatively by a residual risk factor $q = 0.03$ (that is, a $97\\%$ relative risk reduction); COCs are assumed to confer no contraceptive protection until after $7$ consecutive days of correct use.\n- Assume independence of conception events across acts within a cycle for the purpose of calculating the overall probability of pregnancy.\n\nUsing these assumptions and fundamental probability rules, calculate the overall probability of unintended pregnancy in this cycle. Express the final probability as a decimal and round your answer to four significant figures.",
            "solution": "The problem statement is assessed to be valid. It is scientifically grounded in a simplified but reasonable model of reproductive biology, well-posed with all necessary information provided, and objective in its language. It does not violate any of the specified criteria for invalidity. We may therefore proceed with a formal solution.\n\nLet $\\mathcal{P}$ denote the event of an unintended pregnancy in the cycle under consideration. Our goal is to calculate the probability $\\mathbb{P}(\\mathcal{P})$.\n\nThe problem specifies that the day of ovulation, $O$, is a random variable with a discrete uniform distribution over the set $\\{14, 15, 16\\}$. The probability for each possible day of ovulation is therefore:\n$$\n\\mathbb{P}(O=14) = \\mathbb{P}(O=15) = \\mathbb{P}(O=16) = \\frac{1}{3}\n$$\nWe can calculate the total probability of pregnancy by applying the Law of Total Probability, conditioning on the day of ovulation:\n$$\n\\mathbb{P}(\\mathcal{P}) = \\sum_{o \\in \\{14, 15, 16\\}} \\mathbb{P}(\\mathcal{P} | O=o) \\mathbb{P}(O=o)\n$$\nGiven the uniform distribution of $O$, this simplifies to:\n$$\n\\mathbb{P}(\\mathcal{P}) = \\frac{1}{3} \\left[ \\mathbb{P}(\\mathcal{P} | O=14) + \\mathbb{P}(\\mathcal{P} | O=15) + \\mathbb{P}(\\mathcal{P} | O=16) \\right]\n$$\nTo find the conditional probabilities $\\mathbb{P}(\\mathcal{P} | O=o)$, it is computationally simpler to first calculate the probability of the complementary event, i.e., no pregnancy, and subtract this from $1$. Let $\\mathcal{P}^c$ denote the event of no pregnancy.\n$$\n\\mathbb{P}(\\mathcal{P} | O=o) = 1 - \\mathbb{P}(\\mathcal{P}^c | O=o)\n$$\nThe problem states that conception events from different acts of intercourse are independent. Therefore, the probability of no pregnancy is the product of the probabilities of no conception from each individual act. The acts of intercourse occurred on cycle days $I = \\{14, 16, 18, 20\\}$. Let $p_{i,o}$ be the probability of conception from an act on day $i$ given ovulation on day $o$. Then,\n$$\n\\mathbb{P}(\\mathcal{P}^c | O=o) = \\prod_{i \\in I} (1 - p_{i,o})\n$$\nThe probability $p_{i,o}$ depends on the day of intercourse, $i$, relative to the day of ovulation, $o$. Let this relative day be $k = i - o$. The base probabilities of conception, $p_k$, are given for $k \\in \\{-2, -1, 0, 1\\}$ and are $0$ otherwise.\nThe act on day $14$ was unprotected, so its conception probability is $p_{14, o} = p_{14-o}$.\nThe acts on days $16$, $18$, and $20$ were protected by a condom, which reduces the conception probability by a multiplicative factor $q=0.03$. Thus, for $i \\in \\{16, 18, 20\\}$, the probability is $p_{i,o} = q \\cdot p_{i-o}$.\n\nWe now analyze each case for the day of ovulation $o$:\n\nCase 1: Ovulation on day $o=14$.\nThe fertile window is $\\{14-2, 14-1, 14, 14+1\\} = \\{12, 13, 14, 15\\}$.\n- Intercourse on day $i=14$: The relative day is $k = 14 - 14 = 0$. This act was unprotected. The probability of conception is $p_{14,14} = p_0 = 0.30$.\n- Intercourse on day $i=16$: The relative day is $k = 16 - 14 = 2$. This is outside the defined fertile window, so $p_2 = 0$. Thus, $p_{16,14} = q \\cdot p_2 = 0.03 \\times 0 = 0$.\n- Intercourse on days $i=18$ and $i=20$ are also outside the fertile window, so their conception probabilities are also $0$.\nThe probability of no pregnancy is:\n$$\n\\mathbb{P}(\\mathcal{P}^c | O=14) = (1 - 0.30)(1 - 0)(1 - 0)(1 - 0) = 0.70\n$$\nThe conditional probability of pregnancy is:\n$$\n\\mathbb{P}(\\mathcal{P} | O=14) = 1 - 0.70 = 0.30\n$$\n\nCase 2: Ovulation on day $o=15$.\nThe fertile window is $\\{15-2, 15-1, 15, 15+1\\} = \\{13, 14, 15, 16\\}$.\n- Intercourse on day $i=14$: The relative day is $k = 14 - 15 = -1$. This act was unprotected. The probability of conception is $p_{14,15} = p_{-1} = 0.25$.\n- Intercourse on day $i=16$: The relative day is $k = 16 - 15 = 1$. This act was protected. The probability of conception is $p_{16,15} = q \\cdot p_{+1} = 0.03 \\times 0.08 = 0.0024$.\n- Intercourse on days $i=18$ and $i=20$ are outside the fertile window ($k=3$ and $k=5$, respectively), so their conception probabilities are $0$.\nThe probability of no pregnancy is:\n$$\n\\mathbb{P}(\\mathcal{P}^c | O=15) = (1 - 0.25)(1 - 0.0024)(1 - 0)(1 - 0) = 0.75 \\times 0.9976 = 0.7482\n$$\nThe conditional probability of pregnancy is:\n$$\n\\mathbb{P}(\\mathcal{P} | O=15) = 1 - 0.7482 = 0.2518\n$$\n\nCase 3: Ovulation on day $o=16$.\nThe fertile window is $\\{16-2, 16-1, 16, 16+1\\} = \\{14, 15, 16, 17\\}$.\n- Intercourse on day $i=14$: The relative day is $k = 14 - 16 = -2$. This act was unprotected. The probability of conception is $p_{14,16} = p_{-2} = 0.15$.\n- Intercourse on day $i=16$: The relative day is $k = 16 - 16 = 0$. This act was protected. The probability of conception is $p_{16,16} = q \\cdot p_0 = 0.03 \\times 0.30 = 0.009$.\n- Intercourse on days $i=18$ and $i=20$ are outside the fertile window ($k=2$ and $k=4$, respectively), so their conception probabilities are $0$.\nThe probability of no pregnancy is:\n$$\n\\mathbb{P}(\\mathcal{P}^c | O=16) = (1 - 0.15)(1 - 0.009)(1 - 0)(1 - 0) = 0.85 \\times 0.991 = 0.84235\n$$\nThe conditional probability of pregnancy is:\n$$\n\\mathbb{P}(\\mathcal{P} | O=16) = 1 - 0.84235 = 0.15765\n$$\n\nFinally, we combine these conditional probabilities to find the total probability of pregnancy:\n$$\n\\mathbb{P}(\\mathcal{P}) = \\frac{1}{3} \\left[ \\mathbb{P}(\\mathcal{P} | O=14) + \\mathbb{P}(\\mathcal{P} | O=15) + \\mathbb{P}(\\mathcal{P} | O=16) \\right]\n$$\n$$\n\\mathbb{P}(\\mathcal{P}) = \\frac{1}{3} (0.30 + 0.2518 + 0.15765) = \\frac{1}{3} (0.70945)\n$$\n$$\n\\mathbb{P}(\\mathcal{P}) \\approx 0.2364833...\n$$\nThe problem requires the answer to be rounded to four significant figures.\n$$\n\\mathbb{P}(\\mathcal{P}) \\approx 0.2365\n$$",
            "answer": "$$\n\\boxed{0.2365}\n$$"
        }
    ]
}